Timeline
Moderna
US mRNA vaccine company; running Phase 3 H5N1 trial and new CEPI-backed Bundibugyo Phase 1 programme.
6 of 6 entries (6 events, 0 interactions)
Filters
#78 Jun
Mentioned in: CEPI funds a fourth Ebola vaccine
Pandemics and Biosecurity#61 Jun
Received $50m CEPI commitment for Bundibugyo mRNA candidate through Phase 1
Pandemics and Biosecurity: $112m for vaccines, none for the wards#421 May
CEPI rescues Moderna H5N1 vaccine trial
Pandemics and Biosecurity#317 May
Mentioned in: No vaccine, no treatment, no MCM
Pandemics and Biosecurity#212 May
Mentioned in: Idaho dairy H5N1: 1 to 59 herds in twelve days
Pandemics and Biosecurity#122 Apr